Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32196
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhor, Yet H-
dc.contributor.authorFarooqi, Malik-
dc.contributor.authorHambly, Nathan-
dc.contributor.authorJohannson, Kerri A-
dc.contributor.authorMarcoux, Veronica-
dc.contributor.authorFisher, Jolene H-
dc.contributor.authorAssayag, Deborah-
dc.contributor.authorManganas, Helene-
dc.contributor.authorKhalil, Nasreen-
dc.contributor.authorKolb, Martin-
dc.contributor.authorRyerson, Christopher J-
dc.date2022-09-
dc.date.accessioned2023-02-21T23:54:04Z-
dc.date.available2023-02-21T23:54:04Z-
dc.date.issued2023-02-
dc.identifier.citationChest 2023en_US
dc.identifier.issn1931-3543-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32196-
dc.description.abstractFunctional capacity, as measured by the 6-min walk test (6MWT), is often reduced in fibrotic interstitial lung disease (ILD). This study evaluated longitudinal changes and the prognostic significance of 6MWT parameters, and explored change in oxygenation status as a physiological criterion to define disease progression in patients with fibrotic ILD.en_US
dc.language.isoeng-
dc.subject6-min walk testen_US
dc.subjecthypoxemiaen_US
dc.subjectidiopathic pulmonary fibrosisen_US
dc.subjectinterstitial lung diseaseen_US
dc.subjectprogressive pulmonary fibrosisen_US
dc.titleTrajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleChesten_US
dc.identifier.affiliationRespiratory and Sleep Medicineen_US
dc.identifier.affiliationDepartment of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.en_US
dc.identifier.affiliationDepartment of Medicine, University of Calgary, Calgary, AB, Canada.en_US
dc.identifier.affiliationDepartment of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.en_US
dc.identifier.affiliationDepartment of Medicine, University of Toronto, Toronto, ON, Canada.en_US
dc.identifier.affiliationDepartment of Medicine, McGill University, Montreal, QC, Canada.en_US
dc.identifier.affiliationDépartement de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.en_US
dc.identifier.affiliationDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.en_US
dc.identifier.affiliationCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.doi10.1016/j.chest.2022.08.2233en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36089070-
dc.description.volume163-
dc.description.issue2-
dc.description.startpage345-
dc.description.endpage357-
dc.subject.meshtermssecondaryLung Diseases, Interstitial/diagnosis-
dc.subject.meshtermssecondaryLung Diseases, Interstitial/epidemiology-
dc.subject.meshtermssecondaryLung Diseases, Interstitial/complications-
dc.subject.meshtermssecondaryHypoxia/diagnosis-
dc.subject.meshtermssecondaryHypoxia/complications-
local.name.researcherKhor, Yet H
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

152
checked on May 12, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.